Tag Archives: Sarah Eshelman

Archive insights.

All Insights

Writing

Sara Eshelman

Nolan Shah

Clear Filters

Spero Investment Thesis

Why We Invested in Canopy

by Nolan Shah and Andrew Parker • Jan 8, 2026

Leading Canopy's $8M Series A.

Writing

Opportunities in Tech-Bio

by Nolan Shah • Nov 3, 2025

The technologies making it faster, better, and cheaper to get life-saving medicines to patients.

Spero Investment Thesis

Why We Invested in Persist AI

by Sara Eshelman and Nolan Shah • May 19, 2025

Leading Persist's Series A.

Writing

Exposomics

by Nolan Shah • Apr 3, 2025

Science's next moonshot.

Writing

Scaling Specialty Care

by Nolan Shah • Mar 27, 2025

Hinge Health's IPO and how we think about tech-enabled services.

Spero Investment Thesis

Why We Invested in Aralez Bio

by Sara Eshelman • Oct 30, 2024

Co-leading Aralez Bio's $12M Series A.

Writing

Why Built Environment is Important

by Nolan Shah • Jun 12, 2024

City design as the key to unlocking better health.

Spero Investment Thesis

Why We Invested in Tiny Health

by Sara Eshelman • Jun 11, 2024

Leading Tiny Health's $8.5M Series A.

Writing

Trusting Your Gut

by Nolan Shah • Jan 8, 2024

The microbiome in health and disease.

Writing

Infant nutrition is finally growing up

by Sara Eshelman • Oct 20, 2021

BIOMILQ pioneers a revolutionary breast milk alternative, empowering families and reshaping the future of infant nutrition through their groundbreaking technology and mission-driven approach.